Nalaganje...
Is there a role for [(18)F]-FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literature
PURPOSE: Hypoxia is a major cause of radioresistance in head and neck cancer (HNC), resulting in treatment failure and disease recurrence. (18)F-fluoromisonidazole [(18)F]FMISO PET has been proposed as a means of localising intratumoural hypoxia in HNC so that radiotherapy can be specifically escala...
Shranjeno v:
| izdano v: | Clin Transl Imaging |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2024
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7616449/ https://ncbi.nlm.nih.gov/pubmed/39286295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40336-023-00607-y |
| Oznake: |
Označite
Brez oznak, prvi označite!
|